Previous studies on Caucasian ESCC employing the less quantitative CGH analysis reported 6–21% FGFR1 amplifications in cohorts of 32 and 70 ESCC [24,25]. This evidence concerns the gene FGFR1 and esophageal squamous cell carcinoma.